cancer of thyroid gland
DESCRIPTION
TRANSCRIPT
![Page 1: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/1.jpg)
![Page 2: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/2.jpg)
Dr. Zahoor AhmadPGR, SU-I
SZMC/H. RYK, Pakisatan
![Page 3: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/3.jpg)
![Page 4: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/4.jpg)
![Page 5: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/5.jpg)
Lymph vessels:
drain to Prelaryngeal (Delphian), pretracheal paratracheal nodes.
![Page 6: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/6.jpg)
Parasympathetic vagus
Sympathetic superior, middle, inferior sympathetic ganglia
![Page 7: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/7.jpg)
![Page 8: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/8.jpg)
Superior thyroid v (to IJV) middle thyroid v. (to IJV) Inferior thyroid v. (to
brachiocephalic trunk)
![Page 9: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/9.jpg)
Sim’s triangle1. lateral common Carotid artery2. medially Trachea3. superiorly Inferior pole of
thyroid
![Page 10: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/10.jpg)
Lobule: 20-30 follicles Follicle: functional unit Follicular cells Contains colloid Parafollicular cell or C-cell
![Page 11: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/11.jpg)
![Page 12: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/12.jpg)
![Page 13: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/13.jpg)
![Page 14: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/14.jpg)
1% of total 3/million cases Women 3 times more than men. Peak incidence 40s. Papillary 60%, follicular 20%,
anaplastic 10%, medullary 5%, malignant lymphoma 5%.
![Page 15: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/15.jpg)
RADIATION (most important) Family history of Goiter (MEN-II. ret
oncogene) Personal history of Autoimmune
thyroiditis Inheritance of oncogenes (ret/PTC1,
ret/PTC3) Male sex Age > 45 years
![Page 16: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/16.jpg)
![Page 17: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/17.jpg)
![Page 18: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/18.jpg)
![Page 19: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/19.jpg)
![Page 20: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/20.jpg)
Chief complaints Rapidly growing, Painless, palpable,
irregular, solitary nodule. Cervical lymph node enlargement Associated symptomsNeck pain, hoarseness, dysphagia,
dyspnea, stridor, hemoptysis
![Page 21: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/21.jpg)
Thyroid gland Soft tissues of neck Solid, soft, mobile, or fixed? Tenderness? Laryngoscopy if hoarse preop!
![Page 22: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/22.jpg)
![Page 23: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/23.jpg)
Baseline labs Tumor markers (S. thyroglobulin,
S. calcitonin, CEA, ) CXR TSH, TFTs IDL
![Page 24: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/24.jpg)
FNAC Trucut biopsy Incisional biopsy USG neck CT scan neck & thorax MRI Thyroid scan
![Page 25: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/25.jpg)
![Page 26: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/26.jpg)
![Page 27: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/27.jpg)
Tumors of Follicular Cell OriginDifferentiated„ „ Papillary 60%„ „ Follicular 20%Undifferentiated „ „ Anaplastic 10%
Tumors of Parafollicular„ „ Medullary 5%„Other„ „ Lymphoma 5%
![Page 28: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/28.jpg)
Primary
1. Follicular cells (papillary, follicular, and anaplastic)
2. Para-follicular cells (medullary)3. Lymphocytes (lymphoma)
Secondary1. Metastases2. Local infiltration
![Page 29: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/29.jpg)
„TNM system
![Page 30: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/30.jpg)
T1 2cm T2 2-4cm T3 >4cm, limited to thyroid T4a Any size, invasion of SQ,
trachea, esophagus, RLN, paravertebral fascia, carotid artery
N0 no nodes N1a Level VI N1b All other levels
M0 no metastases M1 distant mets
![Page 31: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/31.jpg)
Stage I T1, N0, M0Stage II T2, N0, M0 T3, N0, M0Stage III T4, N0, M0
any T, N1, M0Stage IV any T, any N,M1
![Page 32: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/32.jpg)
AMES system AGES System GAMES system MACIS system University of Chicago system
![Page 33: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/33.jpg)
Age Metastasis Extent/ extrathyroid Size
![Page 34: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/34.jpg)
Age Grade Extent Size
![Page 35: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/35.jpg)
Metastasis Age Completeness of excision Invasion Size
![Page 36: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/36.jpg)
staging system for papillary carcinoma Class I— disease limited to the thyroid glandClass II— lymph node involvementClass III— extrathyroidal invasionClass IV — distant metastases
![Page 37: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/37.jpg)
Most common (60%) Women 3 times more common 30-40 years of age Radiation exposure as a child Multifocality Slow growing microscopically BRANCHING PAPILLAE are
characteristic Orphan-Annie nuclei
![Page 38: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/38.jpg)
Local invasion invading trachea, RLN. Propensity to spread to the cervical
lymph nodes. Distant spread to bone, lungs.
![Page 39: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/39.jpg)
Second most common (20%) Iodine deficient areas 3 times more in women Presents more advanced in stage than
papillary Late 40’s
![Page 40: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/40.jpg)
Pathology: round, encapsulated, cystic changes, fibrosis, hemorrhages.
Microscopically, neoplastic follicular cells.
Differentiated from follicular adenomas by the presence of capsule invasion, vascular invasion.
Cannot reliably diagnose based on FNA.
![Page 41: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/41.jpg)
Local invasion is similar to papillary cancer with the same presentation.
Cervical metastases are uncommon. Distant metastases is significantly
higher (75%), with lung and bone most common sites.
![Page 42: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/42.jpg)
A variant of follicular, also known as oncocytic carcinoma. More common in women than men, presents in 5th decade of life. Cannot diagnose on FNA Does not take up iodine, so treat
aggressively. Thyroid suppression and radioiodine don’t
work.
![Page 43: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/43.jpg)
5%, female preponderance 75% sporadically, 25% familial. Familial
cases are usually all over the gland, sporadic usually not multifocal.
MEN 2A, MEN2B and FMTC syndromes. Arises from parafollicular cells
![Page 44: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/44.jpg)
Highly lethal form of thyroid cancer Median survival <8 months 10% of all thyroid cancers Affects the elderly 30% of thyroid cancers in patients >70
years 53% have previous benign thyroid
disease
![Page 45: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/45.jpg)
Pathology Classified as large cell or small cell Large cell is more common and has a worse
prognosis Histology - sheets of very poorly
differentiated cells little cytoplasm numerous mitoses
necrosis extrathyroidal invasion
![Page 46: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/46.jpg)
MEN 2a is Sipple syndrome MTC, pheochromocytoma, hyperparathyroidism.
MEN 2b is MTC, pheo, ganglionomas. FMTC is just MTC Medullary cancer in these are most
aggressive, younger age, rapid growth and metastases.
Sporadic painless nodule, symptoms of invasion.
![Page 47: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/47.jpg)
Controversy regarding extent of therapy continues.
Surgical excision whenever possible. Total thyroidectomy has been
mainstay (all apparent thyroid tissue removed).
After surgery, perform radioiodine scan, ablation if residual disease or recurrence.
![Page 48: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/48.jpg)
Radioiodine targets residual thyroid tissue and tumor after thyroidectomy.
Given in diagnostic doses and therapeutic doses to ablate tissue.
![Page 49: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/49.jpg)
Maintained on thyroxine after surgery and ablation. Low TSH levels reduce tumor growth rates and reduce recurrence rates.
Most recommend TSH levels of 0.1 mU/l. Follow-up q 6 months with thyroglobulin
levels and repeat scans. Thyroglobulin is good because well
differentiated tumors produce it.
![Page 50: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/50.jpg)
Suspicion for malignancy Compressive symptoms Cosmetic issues Patient wishes Well-differentiated thyroid carcinoma in
low risk patient (controversial)
![Page 51: Cancer of thyroid gland](https://reader038.vdocuments.mx/reader038/viewer/2022102618/54559edeaf7959d8748b6f6e/html5/thumbnails/51.jpg)
Thank You !